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Research
Cardiovascular morbidity and mortality are
associated with exposure to air pollution par-
ticles (Bremner et al. 1999; Burnett et al.
1999; Peters et al. 2000, 2001; Pope et al.
2004). Data analyzed from 1.2 million adults
in the United States from 1982–1998 linked
10-µg/m3 elevations in particulate matter
(PM) < 10 µm in diameter (PM10) with a 6%
increase in deaths from cardiopulmonary dis-
ease (Pope et al. 2002). Among > 65,000
women followed in the Women’s Health
Initiative study (Miller et al. 2007), a
10-µg/m3 increase in PM < 2.5 µm (PM2.5)
was associated with a 24% increased risk for a
cardiovascular event, and a 76% increase in
the risk of death from cardiovascular disease.
Exposure to PM has been associated with
increased risk for myocardial infarction
(Peters et al. 2001, 2004), cardiac arrhyth-
mias (Peters et al. 2000), increases in blood
pressure (Ibald-Mulli et al. 2001), reductions
in heart rate variability (Gold et al. 2000;
Pope et al. 1999), increased blood markers of
inﬂammation and coagulation (Rückerl et al.
2006), and more rapid progression of athero-
sclerosis (Künzli et al. 2005). Despite con-
vincing epidemiologic evidence linking
particle exposure and cardiovascular disease,
the relevant particle characteristics and mech-
anisms remain poorly deﬁned. 
Ultrafine particles (UFP) (diameter
< 100 nm) have been hypothesized as contrib-
utors to cardiovascular effects of PM. High
concentrations of UFP are found on and near
major highways (Kittelson et al. 2004), where
they may contribute to the increased risk of
myocardial infarction associated with exposure
to trafﬁc (Peters et al. 2004). Their character-
istics suggest that UFP may contribute to the
cardiovascular effects of PM. Compared with
fine particles at similar mass concentrations,
UFP have a higher number concentration and
surface area (Oberdörster et al. 1995),
enhanced oxidant capacity (Brown et al.
2001; Li et al. 2003), greater inflammatory
potential (Oberdörster et al. 1995), and
higher pulmonary deposition efficiency
(Chalupa et al. 2004; Daigle et al. 2003).
They are also more likely to penetrate epithe-
lium and enter the pulmonary interstitium
and vascular space (Stearns et al. 1994). 
We have previously reported that expo-
sure to 50 µg/m3 UFP caused a significant
decrease in the pulmonary diffusion capacity
for carbon monoxide 21 hr after exposure
(Pietropaoli et al. 2004b), as well as changes
in blood leukocyte expression of surface adhe-
sion molecules (Frampton et al. 2006). These
findings together suggest that inhalation of
carbon UFP caused transient reductions in
the pulmonary capillary blood volume,
providing indirect evidence for effects of UFP
on pulmonary endothelial function. 
In this study, we describe the effects of
inhaled UFP on a measure of systemic vascu-
lar function that is associated with coronary
artery disease, forearm venous plethysmo-
graphy, and reactive hyperemia (RH). We
hypothesized that inhalation of elemental car-
bon UFP impairs RH in healthy nonsmokers.
Plasma concentrations of nitrite and nitrate,
products of nitric oxide metabolism, were
measured to determine whether impairment
in vasorelaxation was accompanied by alter-
ations in NO metabolism. Some data from
this study have been presented previously in
abstract form (Pietropaoli et al. 2004a).
Materials and Methods
Subjects. The study was approved by the
Research Subjects Review Board at the
University of Rochester, and subjects pro-
vided written informed consent. We studied
16 healthy never-smokers (eight male and
eight female) 18–40 years of age. Subjects
were required to have no history of pul-
monary or cardiovascular disease, normal
spirometry, a normal electrocardiogram, and
a negative urine pregnancy test (females).
Subjects were instructed to exclude anti-
inflammatory drugs for the duration of the
study and to exclude caffeine, large fatty
meals, and vigorous exercise during and 24 hr
before study days. Subjects were not studied
within 6 weeks of a respiratory infection. 
Study design. The study used a double-
blinded, randomized (blocked by order of
presentation and sex), crossover design. 
Subjects underwent a 2-hr mouthpiece
exposure to either ﬁltered air or carbon UFP,
with four 15-min exercise periods on a
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BACKGROUND: Ultraﬁne particles (UFP) may contribute to the cardiovascular effects of exposure to
particulate air pollution, partly because of their relatively efﬁcient alveolar deposition and potential
to enter the pulmonary vascular space. 
OBJECTIVES: This study tested the hypothesis that inhalation of elemental carbon UFP alters sys-
temic vascular function. 
METHODS: Sixteen healthy subjects (mean age, 26.9 ± 6.5 years) inhaled air or 50 µg/m3 elemental
carbon UFP by mouthpiece for 2 hr, while exercising intermittently. Measurements at preexposure
baseline, 0 hr (immediately after exposure), 3.5 hr, 21 hr, and 45 hr included vital signs, venous
occlusion plethysmography and reactive hyperemia of the forearm, and venous plasma nitrate and
nitrite levels. 
RESULTS: Peak forearm blood ﬂow after ischemia increased 3.5 hr after exposure to air but not UFP
(change from preexposure baseline, air: 9.31 ± 3.41; UFP: 1.09 ± 2.55 mL/min/100 mL; t-test,
p = 0.03). Blood pressure did not change, so minimal resistance after ischemia (mean blood pressure
divided by forearm blood ﬂow) decreased with air, but not UFP [change from preexposure baseline,
air: –0.48 ± 0.21; UFP: 0.07 ± 0.19 mmHg/mL/min; analysis of variance (ANOVA), p = 0.024].
There was no UFP effect on pre-ischemia forearm blood ﬂow or resistance, or on total forearm blood
ﬂow after ischemia. Venous nitrate levels were signiﬁcantly lower after exposure to carbon UFP com-
pared with air (ANOVA, p = 0.038). There were no differences in venous nitrite levels. 
CONCLUSIONS: Inhalation of 50 µg/m3 carbon UFP during intermittent exercise impairs peak fore-
arm blood ﬂow during reactive hyperemia in healthy human subjects.
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[Online 17 December 2007]bicycle ergometer (target minute ventilation
20 L/min/m2 body surface area). A 10-min
break off the mouthpiece was taken after 1 hr
of exposure. Measurements (vital signs, RH,
and phlebotomy) were repeated immediately
(0 hr), 3.5 hr, 21 hr, and 45 hr after exposure.
Exposures were separated by at least 3 weeks. 
Exposure system. Exposures were under-
taken within an environmental chamber,
using a mouthpiece exposure system. Brieﬂy,
the design was a one-pass, dynamic-ﬂow expo-
sure system. The particles [count median
diameter ~ 25 nm; geometric standard devia-
tion (GSD) ~ 1.6] were generated in an argon
atmosphere using an electric spark discharge
between two graphite electrodes, in a commer-
cial generator (Palas Co., Karlsruhe, Germany)
that had been modified to prevent any off-
gassing of organic materials from within the
generator (McDonald et al. 2001). This pro-
duced particles consisting of > 95% elemental
carbon, without metals. The particles were
then deionized and diluted with ﬁltered air to
the desired concentration. Particles were con-
tinuously generated, and the exposure concen-
tration was monitored and regulated during the
exposure. Particle number, mass, and size distri-
butions were monitored on both the inspiratory
and expiratory sides of the subject. The subject
inhaled from a mouthpiece and wore a nose
clip. One-way valves (Hans-Rudolph, Inc.,
Kansas City, MO) prevented rebreathing of
UFP. Air for the control exposures and for dilu-
tion of the particles was passed through char-
coal and high-efﬁciency particle ﬁlters and was
essentially free of particles (0–10 particles/cm3).
The rationale and design of the exposure facility
have been described in detail elsewhere
(Chalupa et al. 2002). 
Reactive hyperemia and nitric oxide
metabolites. We measured RH of the forearm
by venous occlusion plethysmography using
the methodology reported by Delehanty et al.
(1999). After subjects had a light breakfast,
RH was measured supine in a quiet room, at
the same time of day for each exposure, and
before any other measurements such as phle-
botomy and spirometry, because these studies
may influence the measurements. To mini-
mize dietary inﬂuence on plasma nitrate lev-
els, subjects were placed on a low-nitrate diet
on study days. A venous occlusion cuff was
placed around the arm just above the elbow
with the subject in the supine position, with
the forearm at or above the level of the right
atrium. A 1-min ischemic occlusion was per-
formed for preconditioning. Three minutes
later, a pediatric blood pressure cuff was
positioned around the wrist to exclude wrist
flow artifact, and a silicone strain gauge
(Hokanson EC 5R; D.E. Hokanson, Inc.,
Bellevue, WA) was positioned so that it encir-
cled the forearm at its widest diameter. With
the wrist cuff inﬂated, the upper arm cuff was
inflated to 40 mmHg and recordings of
impedance were made for 5 sec. Five cycles of
venous flow occlusion and 10 sec of cuff
deflation were performed, and the results
were averaged. Transient arterial occlusion
was produced by inﬂating an upper arm cuff
to 50 mmHg above systolic pressure for
5 min. Immediately after release of the
occluding cuff, measurements of flow were
obtained at 15-sec intervals for 3 min. Peak
flow was defined as the maximum flow rate
after release of the cuff. Minimal resistance
was the mean arterial blood pressure divided
by the peak flow. Total flow was the area
under the 3-min ﬂow curve.
We measured NO metabolites using the
Sievers 270B NO analyzer (GE Analytical
Instruments, Boulder, CO) equipped with a
purge vessel. We measured the sum of plasma
nitrite and nitrate by reducing nitrate to nitrite
via nitrate reductase (Roche Diagnostics
Corporation, Indianapolis, IN). The resulting
nitrite was then further reduced to NO with
potassium iodide in the purge vessel, and
quantified by the NO analyzer. Injection of
untreated plasma into the potassium iodide in
the purge vessel measured plasma nitrite alone.
We then calculated plasma nitrate concentra-
tions by subtracting plasma nitrite from the
sum of nitrite and nitrate to provide nitrate
concentrations. Standard curves were gener-
ated using known concentrations of sodium
nitrate and sodium nitrite (1.56–100 uM),
and were used to verify the efficacy of the
nitrate reductase. Data were acquired and ana-
lyzed using a Macintosh G4 computer with
MacLab software (ADInstruments, Cupertino,
CA). The lower limit of nitrate detection was
1.56 µM.
Data handling and statistical methods.
We used a standard, two-period crossover
design in which each subject received both
particles and air (Pietropaoli et al. 2004b).
The order of presentation was randomized
Shah et al.
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Table 1. Vital signs before (baseline) and after exposure (mean ± SE).
Exposure Time Oxygen saturation (%) HR (beats/min) Systolic BP (mmHg) HR × BP
Air Baseline 97.4 ± 0.2 77.0 ± 3.5 125.4 ± 3.1 9,618 ± 451
0 hr 97.0 ± 0.2 94.8 ± 4.2 122.5 ± 3.0 11,494 ± 399
3.5 hr 97.4 ± 0.3 77.8 ± 2.8 116.4 ± 3.7 9,027 ± 391
21 hr 97.4 ± 0.2 78.6 ± 2.9 119.2 ± 2.7 9,315 ± 305
45 hr 97.6 ± 0.3 81.8 ± 2.6 120.8 ± 2.9 9,815 ± 257
UFP Baseline 97.5 ± 0.3 76.4 ± 3.8 127.9 ± 3.3 9,770 ± 537
0 hr 97.0 ± 0.2 96.8 ± 4.8 125.7 ± 4.2 12,108 ± 613
3.5 hr 97.4 ± 0.3 81.1 ± 2.9 119.6 ± 3.1 9,666 ± 365
21 hr 97.3 ± 0.3 79.9 ± 2.7 120.4 ± 4.4 9,569 ± 413
45 hr 97.6 ± 0.3 79.1 ± 2.7 121.6 ± 3.6 9,565 ± 342
Figure 1. Change in the product of HR × BP (mmHg) in females (A) and males (B). Data are mean ± SE.
UFP × sex, p = 0.029. 
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Figure 2. Forearm blood ﬂow after ischemia, 0 hr (A) and 3.5 hr (B) after exposure. Data are mean ± SE.
Arrows indicate peak ﬂow, which increased 3.5 hr after air but not UFP exposure. There were no signiﬁ-
cant differences between air and UFP exposure for total ﬂow (area under the curve). 
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UFPseparately for each sex, with half of the sub-
jects receiving each of the two possible orders.
There was a washout period of 3 weeks
between the two exposures to avoid the possi-
bility of carryover effects. Our approach is
based on using mixed models for the analysis
of crossover trials with repeated measure-
ments within treatment (exposure) periods
(Jones and Kenward 2003). Order of presen-
tation and sex were treated as between-subject
factors, and treatment, period, and time
(when repeated measurements were made
after each exposure) were considered within-
subject factors. We performed the approxi-
mate t-tests and F-tests (Verbeke and
Molenberghs 2000) comparing UFP versus
filtered air exposure and evaluating signifi-
cance of other factors (e.g., time). A p < 0.05
was considered statistically signiﬁcant.
Results
Subjects and UFP characteristics. We studied
16 subjects, 8 male and 8 female, with mean
(± SD) age 26.9 ± 6.5 years. The mean
(± SD) UFP exposure parameters were as fol-
lows: target mass concentration of 50 µg/m3,
with a measured mass concentration of
50.0 ± 3.9 µg/m3, particle number concentra-
tion 10.8 ± 1.7 × 106 particles/cm3, and parti-
cle count median diameter 27.9 ± 2.2 nm,
with a GSD of 1.65 ± 0.02.
Heart rate, blood pressure, and oxygen
saturation. There were no effects of UFP
exposure on oxygen saturation, heart rate, or
blood pressure (Table 1). The analysis of vari-
ance (ANOVA) revealed a significant inter-
action between sex and exposure for the
heart-rate–systolic-blood-pressure product
(HR × BP), an indicator of cardiac work (p =
0.029). Males but not females showed a
greater increase in HR × BP immediately
after exposure to UFP than to air (Figure 1).
There were no other convincing sex-specific
responses.
Forearm blood flow and reactive hyper-
emia. Figure 2 shows the forearm blood ﬂow
after ischemia at 0 and 3.5 hr after exposure
to air and UFP. Time 0 represents the peak
flow measured on release of the occluding
cuff. At 3.5 hr after exposure (Figure 2B), a
small reduction in peak flow was seen with
UFP relative to air exposure, with no differ-
ences for the subsequent measurements.
Figure 3 shows the peak flow and minimal
resistance as changes from preexposure base-
line at all time points. Peak flow increased,
and minimal resistance decreased, 3.5 hr after
exposure to air. This increase in peak ﬂow was
not seen with UFP exposure. The difference
in peak ﬂow at this time point was signiﬁcant
by crossover paired t-test [change from pre-
exposure baseline, air: 9.31 ± 3.41; UFP: 1.09 ±
2.55 mL/min/100 mL; p = 0.034 (Figure 3A)]
but there was no difference across the entire
48-hr measurement period by ANOVA
(exposure–time interaction, p = 0.143). The
difference in minimal resistance was signifi-
cant by ANOVA [change from preexposure
baseline, air: –0.48 ± 0.21; UFP: 0.07 ± 0.19
mmHg/mL/min; exposure–time interaction,
p = 0.024 (Figure 3B)]. There was no UFP
effect on baseline ﬂow, baseline resistance, or
total ﬂow.
Nitrite and nitrate. Venous nitrate levels
decreased after UFP exposure, and were sig-
niﬁcantly lower than after air exposure [UFP:
29.61 ± 3.41 µM; air: 32.52 ± 2.79 µM
21 hr after exposure, p = 0.038 by ANOVA
(Figure 4B)]. Venous nitrite levels also
decreased, but the changes were not statisti-
cally significant (p = 0.286). The changes in
peak RH 3.5 hr after UFP but not air expo-
sure were significantly correlated with the
changes in plasma nitrate levels immediately
after exposure (Figure 5), but not with
changes in nitrate levels at subsequent meas-
urements. There were no signiﬁcant relation-
ships between changes in RH and BP × HR. 
Discussion
These are the ﬁrst human experimental stud-
ies examining the systemic vascular effects of
breathing an aerosol of pure UFP. The parti-
cles consisted of elemental carbon, without
Vascular effects of ultraﬁne particles
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Figure 5. Relationship between peak forearm blood flow (change from pre-UFP exposure to 3.5 hr after
exposure) and plasma nitrate concentrations (change from pre-UFP exposure to 0 hr after exposure).
(A) UFP (r = 0.69, p = 0.003). (B) Air (r = 0.30, p = 0.26). There was no signiﬁcant relationship between fore-
arm blood ﬂow and nitrate levels after air exposure. 
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Figure 3. Changes from preexposure baseline in peak ﬂow (A) and minimal resistance (B) at all time points.
Data are mean ± SE. Peak ﬂow increased, and minimal resistance decreased, 3.5 hr after air but not UFP
exposure. The difference in peak ﬂow 3.5 hr after exposure was signiﬁcant by paired t-test (p = 0.034) but not
by ANOVA (p = 0.143). The difference in minimal resistance was signiﬁcant by ANOVA (UFP × time, p = 0.024). 
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Figure 4. Venous plasma concentrations of nitrite (A) and nitrate (B). Data are mean ± SE. Both nitrite and
nitrate levels decreased after UFP exposure; the changes in nitrate were signiﬁcant by ANOVA (p = 0.038). 
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Time Timeorganic compounds or metals that have been
implicated in PM effects. We tested the
hypothesis that inhalation of carbon UFP
impairs forearm RH in healthy nonsmokers.
Peak hyperemic flow during RH increased,
and minimal vascular resistance decreased,
3.5 hr after air exposure with intermittent
exercise. Breathing UFP blunted these
changes (Figure 2). There was no signiﬁcant
effect of UFP on total forearm flow during
RH. UFP exposures significantly reduced
venous nitrate concentrations. 
We also found an increase in HR × BP in
males after UFP exposure [exposure–sex
interaction, p = 0.03 (Figure 1)]. Hormonal
influences may have protected the females
from this effect. HR × BP, or the rate–pres-
sure product, is a well-recognized noninvasive
estimate of myocardial work, although the
cardiac pressure–volume loop is the gold stan-
dard for assessing contractility. Changes in
HR × BP predict myocardial oxygen con-
sumption during exercise (Gobel et al. 1978),
and may reﬂect changes in cardiac function or
peripheral vascular tone. Not all changes in
cardiac oxygen consumption are reﬂected by
HR × BP. However, increases in HR × BP
would be expected to worsen myocardial
ischemia in patients with critical coronary
artery disease. Some studies have observed
increases in blood pressure associated with
exposure to ambient PM (Ibald-Mulli et al.
2001; Urch et al. 2005), but other studies
have not (Ibald-Mulli et al. 2004). 
Endothelial dysfunction is an initial step in
the development of atherosclerosis (Quyyumi
1998), and an important factor in the develop-
ment of hypertension and heart failure
(Corretti et al. 2002). Impaired endothelium-
dependent vascular reactivity has been linked
epidemiologically to unstable angina, myocar-
dial infarction, and cardiovascular deaths, even
in the absence of obstructive coronary artery
disease (Halcox et al. 2002). Forearm venous
plethysmography is a well-established method
for assessing systemic vascular function,
with defined accuracy and reproducibility
(Joannides et al. 2006). The increase in ﬂow
after infusion of acetylcholine is considered by
many to be the “gold standard” for measuring
endothelial function, and is predictive of future
cardiovascular events (Heitzer et al. 2001;
Perticone et al. 2001). In this study, we chose
not to perform acetylcholine infusion during
RH to avoid the risk and discomfort of arterial
catheterization, and to avoid possible effects on
subsequent measurements of RH and plasma
NO products. Forearm blood ﬂow during RH
correlates well with vasodilation during maxi-
mal acetylcholine infusion (Higashi et al.
2001). RH is not primarily endothelium-
dependent (Tagawa et al. 1994), but initiates
upstream flow-mediated dilatation, which is
endothelium-dependent. 
The increase in peak flow during RH
3.5 hr after air exposure may be a response to
the intermittent exercise during exposure. In a
recent study of 12 sedentary subjects
(Bousquet-Santos et al. 2005), forearm blood
flow during RH increased 10 and 60 min
after 10 min of maximal exercise, and
returned to baseline levels 120 min after exer-
cise. Our subjects required some degree of ﬁt-
ness to perform 2 hr of intermittent exercise;
it is possible that the increased ﬁtness level of
our subjects, together with the prolonged
intermittent exercise, caused a more delayed
and persistent increase in peak ﬂow. It is well
established that chronic exercise improves
endothelial function (Clarkson et al. 1999;
Rakobowchuk et al. 2005). Diurnal variation
could also be responsible for the increase at
3.5 hr after exposure, because this measure-
ment was performed in the afternoon. In con-
trast, all other measurements were performed
earlier in the day. Artifact introduced by
order of exposure or participant bias was pre-
vented by the double-blind, randomized,
crossover study design. Although the reason
for the delayed increase in peak ﬂow after air
exposure is not entirely clear, exposure to
UFP appeared to block the effect. 
We measured venous concentrations of
nitrate and nitrite as products of NO metabo-
lism. Nitrate levels decreased signiﬁcantly after
UFP, relative to air exposure. Reductions in
venous nitrate levels immediately after UFP
exposure correlated significantly with the
reductions in peak forearm blood ﬂow 3.5 hr
after exposure (Figure 5), although changes in
nitrate levels at other times did not correlate
with forearm ﬂow. 
NO, produced by endothelial cells from
L-arginine via NO synthase, mediates vasodila-
tion in both pulmonary and systemic vascular
beds (Ikeda et al. 1995; Joannides et al. 1995).
The generation of NO is driven by an inﬂux of
calcium via calcium-activated potassium chan-
nels, which activate endothelial NO synthase
(Cooke et al. 1991), and by calcium-indepen-
dent mechanisms associated with blood ﬂow
shear stress (Fleming et al. 1998). However,
RH is governed by other factors in addition to
NO; infusion of an NO synthase inhibitor into
the forearm circulation only partially blocks
RH. Furthermore, the peak ﬂow response dur-
ing RH does not appear to be mediated by
NO, and may represent a response to tissue
hypoxia, adenosine accumulation, vasodilating
prostaglandins, myogenic factors, or endothe-
lium-dependent hyperpolarizing factor
(Tagawa et al. 1994). Because NO does not
appear to be important in regulating peak ﬂow
during RH, it seems unlikely that the UFP
effects on peak ﬂow observed in our study are
directly related to UFP effects on NO. 
Inhalation of UFP may deplete NO by
delivering reactive chemical species to the
vascular endothelium. When compared on a
particle mass basis, UFP have greater oxidant
capacity than larger particles (Brown et al.
2001; Li et al. 2003), possibly related to their
high surface area and potential to adsorb
reactive chemical species from the air.
Furthermore, UFP can cross cell membranes
via diffusional mechanisms, entering cell nuclei
and mitochondria (Geiser et al. 2005). UFP
and their burden of reactive chemical species
may enter the pulmonary vascular space and
then the systemic circulation, although the
degree to which this occurs in humans is
unclear (Mills et al. 2006; Nemmar et al.
2002). Reactive oxygen species formed as a
result of particle exposure may react with NO,
forming peroxynitrite, in turn perpetuating the
oxidant injury that contributes to endothelial
dysfunction and atherosclerosis.
Other mechanisms may be involved,
including lung inflammatory responses with
secondary vascular effects. However, our pre-
vious studies have found no evidence for air-
way inflammation, as measured by sputum
induction and exhaled NO, in response to
carbon UFP exposure (Frampton et al. 2004;
Pietropaoli et al. 2004b, 2004c). In a recent
study, recovery of inﬂammatory cells in bron-
choalveolar lavage ﬂuid did not increase 18 hr
after exposure to concentrated ambient UFP
(Samet et al. 2007). Thus airway inflamma-
tion is unlikely to explain the vascular effects
of UFP exposure. 
Epidemiologic, panel, and other clinical
studies also support the hypothesis that expo-
sure to particulate matter, including UFP,
alters endothelial function. In a large panel
study of people with diabetes (O’Neill et al.
2005), several different measures of PM expo-
sure were signiﬁcantly associated with reduc-
tions in vascular reactivity. Recently, Künzli
et al. (2005) found a significant relationship
between long-term PM exposure and a
marker of atherosclerosis, the thickness of the
carotid artery endothelium measure by ultra-
sound. Short-term inhalation of concentrated
ambient particles plus ozone caused systemic
vasoconstriction in resting human subjects
(Brook et al. 2002), and the effect appeared
to be most strongly related to the organic and
elemental carbon content of the particles
(Urch et al. 2004). Inhalation of diesel
exhaust for 1 hr, with intermittent exercise,
attenuated the forearm vasodilation response
to infusion of both acetylcholine and nitro-
prusside, but not verapamil, in human sub-
jects, both 2 and 6 hr after exposure (Mills
et al. 2005). This suggests that diesel exhaust,
which is rich in UFP and elemental carbon,
impairs both endothelium-dependent and
-independent vasodilation. However, the
diesel studies used PM concentrations
approximately 6-fold higher (~ 300 µg/m3)
than our study (50 µg/m3), and included
Shah et al.
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dioxide and CO. 
In vitro and in vivo animal studies also pro-
vide evidence of a relationship between particle
inhalation and endothelial dysfunction. For
example, Batalha et al. (2002) reported that
concentrated ambient particles induced vaso-
constriction of small pulmonary arteries in rats.
Instillation of residual oil ﬂy ash increased pul-
monary artery pressure in rats, via mechanisms
involving epidermal growth factor (Huang
et al. 2002). Urban particles caused constric-
tion of rat pulmonary artery rings, via the
angiotensin-I receptor (Li et al. 2005).
Furthermore, extracts of particles from motor-
cycle exhaust enhanced vasoconstriction
in vitro, via pathways involving reactive oxygen
species and calcium ﬂux (Tzeng et al. 2003). 
We have shown previously that exposure
to carbon UFP with intermittent exercise
causes a signiﬁcant decrease in the pulmonary
diffusion capacity for CO (Pietropaoli et al.
2004b), and reduces peripheral blood leuko-
cyte expression of some adhesion molecules
(Frampton et al. 2006). Both of these effects
may result from pulmonary vasoconstriction.
Effects on peripheral blood leukocytes were
generally maximal at 3.5 hr after exposure—
similar to the timing of effects on RH in the
present study. Taken together, our data sug-
gest that inhalation of carbon UFP with inter-
mittent exercise alters both pulmonary and
systemic vascular function. 
There are limitations to this study. Effects
of breathing laboratory-generated carbon
UFP may not be representative of ambient
UFP, although ambient UFP contain elemen-
tal carbon. The mass concentration of parti-
cles used in this study (50 µg/m3) and the
particle number concentrations (~ 107/cm3)
exceed those encountered in most outdoor
environments, although particle numbers on
major highways can reach peaks of 107 parti-
cles/cm3 (Kittelson et al. 2004). The subjects
were healthy lifetime nonsmokers, without
signiﬁcant cardiovascular disease, and do not
represent those most susceptible to the cardio-
vascular effects of PM exposure. Exposures
were by mouthpiece, which bypasses nasal
clearance mechanisms and alters breathing
patterns. However, UFP in the 20- to 40-nm
size range are predicted to have relatively low
nasal deposition (Daigle et al. 2003), so
oral–nasal breathing would not be expected to
substantially reduce UFP pulmonary deposi-
tion in these studies. Finally, our study, like
most human controlled exposure studies,
included a relatively small number of subjects,
which limited the statistical power. However,
the observation of effects on both vascular
function and NO metabolism provide bio-
logic plausibility to our ﬁndings. 
The observed effects are small and not
clinically important for healthy subjects.
However, for patients with critical coronary
artery disease, small changes in vascular
responsiveness combined with increased
myocardial oxygen demands could worsen
ischemia and precipitate adverse events. For
example, in a recent clinical study (Mills et al.
2007), exposures to diluted diesel exhaust
increased the myocardial ischemic burden in
men with stable coronary artery disease and
previous myocardial infarction. Based on our
initial ﬁndings in healthy volunteers, it seems
highly plausible that inhalation of UFP would
present risks similar to that for diesel exhaust
in patients with coronary artery disease.
Taken together with other human and animal
studies of PM exposure, there is increasingly
compelling evidence that inhalation of PM
impairs systemic endothelial function. Our
ﬁndings support a role for UFP in the vascu-
lar effects of PM exposure. 
Conclusion
In comparison with air exposure, inhalation
of 50 µg/m3 carbon UFP reduced peak hyper-
emic forearm blood flow, increased minimal
vascular resistance, and reduced plasma
nitrate concentrations. These ﬁndings support
the hypothesis that inhalation of UFP impairs
systemic vascular function and reduces NO
bioavailability. These effects represent poten-
tial mechanisms linking particle exposure and
adverse cardiovascular effects.
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